Jynarque™ (tolvaptan) – New orphan drug approval
April 24, 2018 - Otsuka announced the FDA approval of Jynarque (tolvaptan), to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD).
Download PDF
